Survival analysis of publically available datasets (Fig 5C and 5D) showed that higher expression of MCT1 and GLUT1 are associated with poor survival in ADC patients and therefore may make promising prognostic markers. This evidence concerns the gene SLC16A1 and AIDS dementia complex.